| Literature DB >> 23044407 |
E S Pronker1, E Claassen, A D M E Osterhaus.
Abstract
As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success?Entities:
Mesh：
Substances：
Year: 2012 PMID： 23044407 DOI： 10.1016/j.vaccine.2012.09.071
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641